Microsoft word - tetracycline usp.doc

MATERIAL SAFETY DATA SHEET
TETRACYCLINE USP
___________________________________________________________________________________

SECTION 1 - CHEMICAL PRODUCT AND COMPANY INFORMATION
American International Chemical, Inc.

Emergency Number: Chemtrec
800-424-9300
703-527-3887
Framingham, MA 01701
Information Number:
800-238-0001
____________________________________________________________________________________
SECTION 2 - COMPOSITION AND INFORMATION ON INGREDIENTS

100% Tetracycline
____________________________________________________________________________________
SECTION 3 - HAZARDS IDENTIFICATION

EMERGENCY OVERVIEW: An odorless yellow powder that presents little or no health hazard and no unusual
hazard if involved in a fire.
POTENTIAL HEALTH EFFECTS:

Skin:
May cause skin irritation.
Eyes: May cause irritation or burning.
Inhalation: May cause irritation to the respiratory tract.
Ingestion: Not a hazard with normal industrial usage.
____________________________________________________________________________________
SECTION 4 - FIRST AID MEASURES

Skin:
Immediately wash skin with soap and water for at least 15 minutes.
Eyes: Immediately flush with plenty of water for at least 15 minutes, holding eye lids apart.
Inhalation: Remove to the fresh air. If not breathing give artificial respiration. If breathing is difficult,
Ingestion: Wash out mouth with water.
On All Of The Above: Consult a physician if symptoms persist.
___________________________________________________________________________________

SECTION 5 - FIRE FIGHTING MEASURES

Flash Point: Non Combustible
Flammable Limits: Non Combustible

Extinguishing Media: Use media that is appropriate to treat surrounding fire.
Special Fire Fighting Procedures:
Use fire fighting procedure that is appropriate to treat surrounding fire. All firefighters should use self-
contained breathing apparatus and full fire-fighting turn-out gear.
Unusual Fire Explosion Hazard: During a fire, irritating and highly toxic gasses may be generated by thermal
decomposition or combustion.

Auto Ignition Temperature: Not Applicable
____________________________________________________________________________________
SECTION 6 - ACCIDENTAL RELEASE MEASURES
Isolate hazard area and deny entry to unnecessary or unprotected personnel.
Contain spill, sweep up, collect and place in a disposal container. Avoid runoff into storm sewers and
ditches which lead to waterways.
____________________________________________________________________________________
SECTION 7 - HANDLING AND STORAGE
Avoid contact with skin, eyes and clothing. Use with adequate ventilation. Avoid breathing dust. Use
normal personal hygiene and housekeeping. Store in cool dry area away from other incompatible
materials. Product is slightly hygroscopic and should be stored in a dry area to prevent moisture pick up
and caking.
____________________________________________________________________________________
SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
RESPIRATORY PROTECTION: Use NIOSH/MSHA approved respirators.
VENTILATION REQUIREMENTS: Ventilate as necessary to eliminate dust from the work area and maintain
concentrations below the limit.
SKIN AND EYE PROTECTION: Use rubber or neoprene gloves, chemical goggles and clothing sufficient to
protect skin from dust.
WORK, HYGIENIC PRACTICES:
As required to protect skin and eyes from dust, safety showers and/or eye wash should be available. Do not
leave food or smoke in work area. Wash thoroughly and remove or clean any contaminated clothing.
EXPOSURE LIMITS: None Established
____________________________________________________________________________________


SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES

Boiling Point: Not Applicable Vapor Pressure (MM Hg): Not Applicable Vapor Density (AIR=1): Not Applicable Specific Gravity (H20=1): Not Available
Percent Volatile by Volume (%): Not Applicable
Melting Point: Not Applicable
Evaporation Rate (Butyl Acetate=1): Not Applicable
Solubility in Water: Very slightly soluble.
pH: 3.0 – 7.0
____________________________________________________________________________________
SECTION 10 - STABILITY AND REACTIVITY
CHEMICAL STABILITY: Stable under normal temperatures and pressures.
HAZARDOUS POLYMERIZATION: Will not occur under normal conditions.
HAZARDOUS DECOMPOSITION PRODUCTS: When heated to decomposition material emits toxic fumes.
Emits toxic fumes under fire conditions
KEEP AWAY FROM: High temperatures and moisture.
SECTION 11 - TOXICOLOGICAL INFORMATION
LD50 – 3000 mg/kg – Oral Administration
____________________________________________________________________________________
SECTION 12 - ECOLOGICAL INFORMATION
The product has an effect on the environment and aquatic toxicity.
____________________________________________________________________________________
SECTION 13 - DISPOSAL CONSIDERATIONS

Dispose of in accordance with all federal, state and local regulations.
RCRA WASTE #: Not Listed
____________________________________________________________________________________


SECTION 14 - TRANSPORTATION INFORMATION

D.O.T. SHIPPING NAME: TETRACYCLINE USP

____________________________________________________________________________________

SECTION 15 - REGULATORY INFORMATION

OSHA STATUS: Not listed
TSCA STATUS: Listed
CERCLA REPORTABLE REQUIREMENTS: (RQ) None
SARA TITLE III INFORMATION:

Section 302 Extremely Hazardous Substance Not listed ____________________________________________________________________________________
SECTION 16 - OTHER INFORMATION


Reason for Issue: Changed Date

This information is given without any warranty or representation. It is believed to be correct but
does not claim to be all inclusive and shall be used only as a guide. American International
Chemical, Inc., shall not be held liable for any damage resulting from handling or contact with the
above product. It is offered solely for your consideration, investigation and verification.

Source: http://www.aicma.com/msds/Tetracycline%20USP.pdf

Seno_in_klinische studien_111017

Klinische Studien im Brustzentrum St. Elisabeth-Krankenhaus Leipzig Die Behandlung von Brustkrebs wird ständig erforscht, um die Therapie und die Überlebenschancen bei Brustkrebs weiter zu verbessern. Neben der Standardtherapie besteht oftmals die Möglichkeit, an einer klinischen Studie teilzunehmen. Es gibt Studien für die verschiedensten Schritte der Behandlung. Durch klinische Studien

Microsoft word - december.doc

Källa: Diverse artiklar från Fred H. Gage, Salk Institute, La Jolla, CA USA Under i stort sett dess hundraåriga historia har neurovetenskapen hävdat att en mogen hjärna är en stabil, oföränderlig, dataliknande maskin med ett minne och med processliknande kraft. Man kan förlora hjärnceller, förlora delar av faktaminnet men man kan framförallt inte skapa nya hjärnceller, har man hä

Copyright ©2018 Sedative Dosing Pdf